403 related articles for article (PubMed ID: 33175203)
1. Late recurrence of hepatocellular carcinoma after radiofrequency ablation: a multicenter study of risk factors, patterns, and survival.
Yang Y; Chen Y; Ye F; Cao X; Xin Y; Wang Y; Lei Y; Li X; Feng D; Zhou X; Fan Q
Eur Radiol; 2021 May; 31(5):3053-3064. PubMed ID: 33175203
[TBL] [Abstract][Full Text] [Related]
2. Predictors and patterns of recurrence after radiofrequency ablation for hepatocellular carcinoma within up-to-seven criteria: A multicenter retrospective study.
Yang Y; Chen Y; Zhang X; Xin Y; Wang Y; Li X; Fan Q; Zhou X; Ye F
Eur J Radiol; 2021 May; 138():109623. PubMed ID: 33711573
[TBL] [Abstract][Full Text] [Related]
3. Early recurrence after radiofrequency ablation for hepatocellular carcinoma: a multicenter retrospective study on definition, patterns and risk factors.
Yang Y; Xin Y; Ye F; Liu N; Zhang X; Wang Y; Li X; Fan Q; Zhou X; Chen Y
Int J Hyperthermia; 2021; 38(1):437-446. PubMed ID: 33724137
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for the recurrence of early hepatocellular carcinoma treated by percutaneous radiofrequency ablation with a multiple-electrode switching system: a multicenter prospective study.
Tan Y; Wang X; Ma K; Zhang L; Li J; Chen P; Zhang B
Int J Hyperthermia; 2022; 39(1):190-199. PubMed ID: 35042449
[TBL] [Abstract][Full Text] [Related]
5. A novel nomogram for prediction of intrahepatic recurrence-free survival in patients with HCC followed by radiofrequency ablation.
Wang B; Wu H; Wang S; Zhang ZY; Wu W; Yan K; Yang W
Br J Radiol; 2024 Mar; 97(1156):844-849. PubMed ID: 38346708
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of percutaneous radiofrequency ablation for periportal hepatocellular carcinoma: tumor recurrence or progression, survival and clinical significance.
Cao S; Lyu T; Fan Z; Guan H; Song L; Tong X; Wang J; Zou Y
Cancer Imaging; 2022 Jan; 22(1):2. PubMed ID: 34983650
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of risk factors and construction of predictive nomogram for early recurrence after radiofrequency ablation of hepatocellular carcinoma].
Han RC; Ma XH; Wang S; Yang Y; Feng B; Liang M; Zhao XM
Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):546-552. PubMed ID: 34034474
[No Abstract] [Full Text] [Related]
8. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
9. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma.
Ng KK; Poon RT; Lo CM; Yuen J; Tso WK; Fan ST
J Gastrointest Surg; 2008 Jan; 12(1):183-91. PubMed ID: 17874276
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation.
Seo JY; Kim W; Kwon JH; Jin EH; Yu SJ; Kim HY; Jung YJ; Kim D; Kim YJ; Yoon JH; Lee HS
Liver Int; 2013 Jul; 33(6):884-93. PubMed ID: 23461618
[TBL] [Abstract][Full Text] [Related]
11. Aspartate aminotransferase-to-platelet ratio index for predicting late recurrence of hepatocellular carcinoma after radiofrequency ablation.
Zhang X; Xin Y; Yang Y; Chen Y; Cao XJ; Wang Y; Fan Q; Zhou X; Li X
Int J Hyperthermia; 2022; 39(1):437-445. PubMed ID: 35249443
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP; Ghanekar A; Greig PD; McGilvray ID; Selzner M; Cattral MS; Grant DR; Lilly LB; Selzner N; Renner EL; Sherman M; Sapisochin G
J Hepatol; 2019 May; 70(5):866-873. PubMed ID: 30615906
[TBL] [Abstract][Full Text] [Related]
13. Feasibility and outcomes of percutaneous radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma after liver transplantation: a single-center experience.
Liu B; Huang G; Xie X; Zhao Q; Su L; Liu M; Li X; Long J; Kuang M; Xie X
Int J Hyperthermia; 2020; 37(1):1202-1209. PubMed ID: 33100042
[TBL] [Abstract][Full Text] [Related]
14. Thermal Injury-induced Hepatic Parenchymal Hypoperfusion: Risk of Hepatocellular Carcinoma Recurrence after Radiofrequency Ablation.
Lee DH; Lee JM; Yoon JH; Kim YJ; Han JK
Radiology; 2017 Mar; 282(3):880-891. PubMed ID: 27643670
[TBL] [Abstract][Full Text] [Related]
15. When to Perform Surgical Resection or Radiofrequency Ablation for Early Hepatocellular Carcinoma?: A Nomogram-guided Treatment Strategy.
Liu PH; Hsu CY; Lee YH; Hsia CY; Huang YH; Su CW; Chiou YY; Lin HC; Huo TI
Medicine (Baltimore); 2015 Oct; 94(43):e1808. PubMed ID: 26512576
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of pan-immune-inflammation value in hepatocellular carcinoma treated by curative radiofrequency ablation: potential role for individualized adjuvant systemic treatment.
Liang X; Bu J; Jiang Y; Zhu S; Ye Q; Deng Y; Lu W; Liu Q
Int J Hyperthermia; 2024; 41(1):2355279. PubMed ID: 38767372
[TBL] [Abstract][Full Text] [Related]
17. Features of extrahepatic metastasis after radiofrequency ablation for hepatocellular carcinoma.
Yoon JH; Goo YJ; Lim CJ; Choi SK; Cho SB; Shin SS; Jun CH
World J Gastroenterol; 2020 Aug; 26(32):4833-4845. PubMed ID: 32921960
[TBL] [Abstract][Full Text] [Related]
18. Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis.
Lin CH; Ho CM; Wu CH; Liang PC; Wu YM; Hu RH; Lee PH; Ho MC
Surg Endosc; 2020 Dec; 34(12):5566-5573. PubMed ID: 31993821
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.
Xu XF; Xing H; Han J; Li ZL; Lau WY; Zhou YH; Gu WM; Wang H; Chen TH; Zeng YY; Li C; Wu MC; Shen F; Yang T
JAMA Surg; 2019 Mar; 154(3):209-217. PubMed ID: 30422241
[TBL] [Abstract][Full Text] [Related]
20. Predicting outcomes for recurrent hepatocellular carcinoma within Milan criteria after complete radiofrequency ablation.
Chen HY; Lu SN; Hung CH; Wang JH; Chen CH; Yen YH; Kuo YH; Kee KM
PLoS One; 2020; 15(11):e0242113. PubMed ID: 33170894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]